Finance

Beta
Lists
IXC:ASX
Invex Therapeutics Ltd
A$0.12
+31.87%
(+0.029) 1D
Jun 12, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for IXC...
Open
A$0.11
High
A$0.12
Low
A$0.11
Mkt. cap
9.12M
Avg. vol.
25.02K
Volume
0.00
52-wk high
A$0.18
52-wk low
A$0.08
EPS
-A$0.01
Shares outstanding
75.15M
Open
A$0.11
High
A$0.12
Low
A$0.11
Mkt. cap
9.12M
Avg. vol.
25.02K
Volume
0.00
52-wk high
A$0.18
52-wk low
A$0.08
EPS
-A$0.01
Shares outstanding
75.15M
News stories
From sources across the web
About Invex Therapeutics Ltd
CEO-
Employees-
Founded2019
Headquarters-
SectorPharmaceutical industry
Websiteinvextherapeutics.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
114.54K
114.54K
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
57.03K
57.03K
63.16K
63.16K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
176.08K
176.08K
358.35K
358.35K
Operating expense
233.10K
233.10K
421.51K
421.51K
Total operating expenses
233.10K
233.10K
421.51K
421.51K
Operating income
-118.56K
-118.56K
-421.51K
-421.51K
Other non operating income
-
-
31.87K
31.87K
EBT including unusual items
-60.17K
-60.17K
-357.79K
-357.79K
EBT excluding unusual items
-60.17K
-60.17K
-357.79K
-357.79K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-60.17K
-60.17K
-357.79K
-357.79K
Net profit margin
-52.53%
-52.53%
-
-
Earnings per share
-
-
-
-
Interest and investment income
58.39K
58.39K
31.85K
31.85K
Interest expense
-
-
-
-
Net interest expenses
58.39K
58.39K
31.85K
31.85K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer